NDI’s model is to identify and select product opportunities in large markets where there is at least one validated product, but where critical clinical needs still exist.
NDI maintains a significant pipeline of commercialization opportunities from three primary sources:
- An extensive network in the medical device and investment community
- Collaborative relations with research and technology transfer organizations and biomedical incubators
- NDI’s own R&D division which designs and develops new products and therapies by leveraging its platform technologies
NDI formally collaborates with leading research and health care institutions including:
NDI also maintains an active facility in North Carolina’s Research Triangle, leveraging strong relationships with Duke University.
- The Ohio Neurostimulation and Neuromodulation Partnership: a collaboration of NDI, Case Western Reserve University, Cleveland Clinic, and MetroHealth Medical Center dedicated to the commercialization of technologies that address critical neurological disorders
- The Cleveland Functional Electronic Stimulation (FES) Center: one of the world’s leading research centers developing advanced neurotech technologies and integrating them into cutting-edge clinical care